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Abstract
Background: The pro-apoptotic protein Siva-1 functions in both extrinsic and intrinsic cell death signaling;
however, the exact contribution of the endogenous Siva-1 to DNA damage-induced apoptosis is unclear.
Using cisplatin, a chemotherapeutic drug, to induce DNA damage and cell death, we determined the role of
Siva-1. Methods: Cisplatin treated HCT116 colorectal carcinoma cells (p53+/+ and -/-) were used in the
study. With the help of recombinant lentivirus that can express siSiva (siRNA that specifically targets Siva-1),
we also generated Siva-1 knockdown HCT116 cells. Apoptosis was determined by tetramethyl rhodamine
methyl ester (TMRM) staining and propidium iodide (PI) staining. Results: Treatment with cisplatin induced
Siva-1 expression in a p53 dependent manner. In Siva-1 knockdown p53+/+ HCT116 colorectal carcinoma
cells, loss of Siva-1 expression conferred significant resistance to cisplatin-induced apoptosis. Although Siva-1
levels were positively regulated by p53, Siva-1-induced apoptosis did not require p53. Despite the fact that
Siva-1 lacks even a minimal BH3 domain, similar to other proapoptotic Bcl2 family members induced by p53,
we showed that Siva-1 mediated apoptosis is characterized by Bax oligomerization and cytochrome c leakage
from mitochondria.The putative amphipathic helical region in Siva-1 (SAH) appeared to function analogously to
a BH3 domain. Conclusion: The p53 induced Siva-1 is one of the effector molecules, which plays a significant
role in DNA damage-induced cell death.
Keywords: Apoptosis, Bcl-2 family, cisplatin, cytochrome c, p53, Siva-1

Background
It is estimated that at least 50% of human cancers can be
attributed to the ablation or dysfunction of the p53 gene.[1] As
a transcription factor, p53 has been implicated in the regulation
of numerous tumor suppressor genes. In cases of irreparable
DNA damage, p53 is well-characterized by its ability to
transcriptionally upregulate various Bcl-2 family target genes
involved in apoptosis.[2] Studies have also identified genes outside
the Bcl-2 family, which facilitate apoptosis and are regulated
by p53.[3]. Among these, the Siva-1 gene is transcriptionally
induced by p53, at levels exceeding that of Bax, in response to
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genotoxic stress.[4] Despite a growing understanding of the role
of p53 in DNA damage response pathways, the exact function
of many of its unique target genes remains to be elucidated.
Siva-1 signaling output influences both extrinsic and
intrinsic apoptotic pathways.[5-10] DNA microarray analyses
have demonstrated enhanced Siva-1 activity in response to
chemotherapeutic agents in several transformed cell lines.[4,11-12]
Further, we have shown that Siva-1 can act synergistically with
cisplatin and promote apoptosis in breast cancer cell lines,
regardless of the p53 or Bcl-2 status.[13] This finding correlates
with our previous observations of direct inhibition of Bcl-2
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and Bcl-xL by Siva-1, in response to genotoxic stress.[8-9] In
the current study, we examined the role of Siva-1 in cisplatinmediated apoptosis in HCT116 p53 +/+ and p53-/-cells.
Using siRNA to abrogate endogenous Siva-1 expression, we
demonstrate the importance of its role in DNA damage-induced
apoptosis in p53 WT cells. In addition, we show that expression
of Siva-1 can promote apoptosis, even in cells devoid of p53
function. Based on its ability to interact with Bcl-2 and Bcl-xL
and to promote Bax oligomerization, we further propose that
Siva-1 functions like a BH3- only pro-apoptotic member of
the Bcl-2 family.
Materials and Methods
Cell lines and Reagents

Colon cancer cells HCT116 p53+/+ and p53-/- (kind gifts
of Dr. Bert Vogelstein, Johns Hopkins University,)) were
cultured in McCoy’s 5A medium, supplemented with 10%
FCS, 1 mM sodium pyruvate, 1 mM HEPES buffer, and 100
U/mL antibiotic/antimycotic (Gibco, Invitrogen). Human T
cell lymphoma Jurkat and MDA MB-231 human breast cancer
cells were maintained with RPMI medium.
The chemotherapeutic reagent cisplatin was purchased from
Sigma and prepared in dimethyl sulfoxide (DMSO); UV
radiation doses were applied via an XL-1000 Spectrolinker
(Spectronics Corp.) UV crosslinker.
The following antibodies were purchased from companies that
have been indicated; respective dilutions are also indicated
for those used in western blotting analysis or intracellular
staining: mouse monoclonal β actin (Sigma, 1:2,000); rabbit
polyclonal caspase-9 (p-10) and Bax (Santa Cruz, 1:500);
rabbit polyclonal Bcl-xL, Bcl-2, and green fluorescence protein
(GFP) (Santa Cruz, 1:1,000); mouse monoclonal GST, Bax,
Hemagglutinin (HA), and c-myc (Santa Cruz, 1:1,000); mouse
monoclonalcytochrome C (BD Biosciences, 1:1,000); mouse
monoclonal cytochrome C oxidase IV (COX IV) (Molecular
Probes, Invitrogen, 1:1,000); Bax 6A7 (BD Biosciences); mouse
monoclonal p53 (Cell Signaling Technologies, 1:1,000); rabbit
IgG-HRP and mouse IgGHRP (Santa Cruz, 1:10,000); mouse
IgG-HRP Trublot (Ebiosciences, 1:1,000); and mouse IgGFITC (Life Source Technologies, 1:200). The Siva-1 antibody
was generated commercially in rabbits, via injection of a
previously described recombinant Siva-1 protein, expressed in
and isolated from BL21 E. coli strains[14]. Rabbit antiserum was
further purified using Thiophilic Resin (Clontech, 1:1,000),
supplemented as above (Gibco).
Recombinant Lentiviruses

Generation of recombinant lentiviruses encoding either a
scrambled control or unique shRNA sequences targeted
2
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against Siva-1 has been previously described.[10] HCT116
p53+/+ and Jurkat cells were infected with equivalent titers
of control and Siva-1 siRNA-producing viruses were applied
to cells that were subsequently incubated for at least 48 hours
prior to each experiment.The cells were further sorted on the
basis of GFP expression (MoFlo High Speed Cell Sorter). The
GFP expression after cell sorting was greater than 90%. The
cell morphology and growth remained unchanged, indicating
negligible cytotoxic effects (data not shown). Knockdown of
endogenous Siva-1 was verified by western blotting with Siva-1
antibody. Lentiviral stocks were propagated in 293T cells via
calcium phosphate co-transfection of pNLSIN (Siva-1 siRNA
or Scrambled siRNA), pcTAT, pcRev, and pHit/G plasmids.
Transfections were performed in the evening and the cell
culture media were changed the following morning; 24 hours
later, the media containing viral stocks were collected, spun
down at 4,000 RPM in a table-top centrifuge to clear cellular
debris, and used directly for infection or stored at 20oC
Cell lysates and Inmmunoblotting

Preparation of whole cell lysates and various immunoblotting
procedures were done according to previously published
procedures.[10-12,15]
Apoptosis

The percentage of cells undergoing apoptosis was determined
by propidium iodide analysis of apoptotic DNA (Sub-G1 peak),
as well as tetramethylrhodamine ester (TMRM) staining of
Jurkat cells, as has been described.[8-10] Apoptosis was quantified
by flow cytometry, on the basis of high GFP expression (siRNA
positive cells), low 7AAD staining and high TMRM patterns.
TMRM negative cells fitting these parameters were considered
apoptotic.
Subcellular Fractionation

This procedure was adapted from previously described
protocols.[15-20] HCT116 p53-/- cells were harvested with
corresponding media using cell scrapers and centrifuged at 200
x g (4oC) for five minutes.The resulting pellet was washed with
PBS (pH 7.4) and spun down, again under the same conditions.
Cells were resuspended in hypotonic buffer (20 mM Hepes, pH
7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM ethylene
glycol tetraacetic acid (EGTA), protease inhibitor cocktail, 1X
(Roche)) and incubated on ice for 10 minutes.They were lysed
in a Dounce homogenizer by applying 50 strokes with a type
B pestle. Hypotonic buffer containing 1M sucrose was added
to the lysates, to obtain a final sucrose concentration of 250
mM. Whole cell lysate samples from the suspension were set
aside and the remaining volumes were centrifuged at 750 x g,
to separate intact cells and nuclei. The resulting pellets were
discarded and the supernatants were centrifuged further at
10,000 x g for 10 minutes, to obtain heavy membrane (HM,
Journal of Carcinogenesis
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mitochondria-enriched) fractions.The supernatants were saved
as the S-100/LM fractions and the HM fraction pellets lysed in
NP40 buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1% NP40,
v/v, 0.1% sodium deoxycholate) for western blotting analysis.
MCF-7 mitochondria were prepared similarly, but disrupted
by nitrogen cavitation.
Chemical Cross-linking

In order to observe Bax oligomers, MDA-MB-231 and HCT116
cell lysates were prepared by fractionation and subsequently
incubated with 10 mM bis-maleimide hexane (BMH, Pierce)
or DMSO (vehicle control), in the dark for 30 minutes, at
room temperature.[15]The reaction was quenched by adding 10
mM β-mercaptoethanol. Samples were prepared for western
blotting, as previously indicated and oligomerization was
determined by molecular weight analysis.

A

Results
Cisplatin-induced Siva-1 expression is p53
dependent

To determine the significance of p53 expression on the proapoptotic function of Siva-1, we took advantage of p53+/+ and
p53-/- HCT116 cells in our studies. Cells of both genotypes
were treated with cisplatin (100 µM) or DMSO for 16 hours
and endogenous Siva-1 levels were analyzed by immunoblotting
whole cell lysates with Siva-1 polyclonal antibody, as described
previously.[14] While we observed a robust induction of Siva-1
in response to cisplatin treatment in p53+/+ cells, we were
unable to detect the protein in p53-/-cells (as compared to
a relatively strong expression of beta-actin, used as a loading
control) [Figure 1A]. To ensure that the cisplatin dose was
sufficient to induce apoptosis, HCT116 cells were analyzed by
propidium iodide staining. Significant levels of sub-G1 apoptotic
DNA were observed in p53+/+ cells (increase from 2.14 to
33.74%); conversely, as expected, p53-/- cells exhibited levels
of apoptosis only slightly higher than that of control treated
cells (4.03 to 9.47%) [Figure 1B].
In order to define the role of endogenous Siva-1 in DNA damageinduced apoptosis and its relationship to p53, we generated
Siva-1 knockdown p53+/+ HCT116 cells using Siva-1
specific siRNA. The cells were transduced with recombinant
lentiviruses encoding either unique Siva-1 siRNA (siSiva) or a
corresponding scrambled control siRNA, as described by Gudi
et al.[10] Since Siva-1 protein expression was not detectable in
untreated cells [Figures 1A, 2A], we tested the effect of cisplatin
treatment on apoptosis in siSiva and control cells. As shown
in Figure 2A, cisplatin treatment induced significant Siva-1
expression in HCT116 p53+/+ cells that were dramatically
reduced by prior transduction with recombinant lentivirus,
capable of expressing siSiva.
Journal of Carcinogenesis
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Figure 1: Cisplatin induces p53 dependent Siva-1 expression.
HCT116 colon cancer p53+/+ and -/- cell lines (gift of Bert Vogelstein,
Johns Hopkins University) were treated with DMSO (0, Control)
or 100 µM cisplatin (CDDP, Sigma), incubated for 16 hours. (A)
Endogenous Siva-1 expression by was determined SDS-PAGE and
immunoblotting of lysates with Siva-1 polyclonal antibody. betaactin served as a loading control. (B) Apoptosis by propidium iodide
staining. Percentages indicate sub-G1 apoptotic DNA analyzed by
flow cytometry (FACScaliber, BD Biosciences)

Siva-1 plays an essential but partial role in DNA damageinduced apoptosis.
We next treated both Siva-1 knockdown and control HCT116
p53+/+ cells for 24 hours, with either cisplatin or DMSO.
Apoptotic cells were quantified by flow cytometry using TMRM
staining, to monitor loss of mitochondrial membrane potential.
While control siRNA treated cells demonstrated a strong
apoptotic response to cisplatin (about five-fold increase over
mock treated cells), the percentage of programmed cell death in
siSiva cells decreased by more than 50% and the difference was
statistically significant at P<0.01 [Figure 2B].To ensure that this
effect was not cell type specific, Jurkat T cells were also similarly
treated. As shown, a significantly diminished level of apoptosis
was observed in siSiva cells treated with cisplatin [Figure 2C].
These findings clearly identify an essential but partial role for
3
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Figure 2: Abrogation of Siva-1 expression significantly impairs cisplatin-mediated apoptosis. (A) HCT116 p53+/+ or (C) Jurkat cells were
transduced with lentiviruses encoding either Siva siRNA (siSiva) or scrambled control (Scr siRNA).Transduced cells were analyzed for
Siva-1 expression (A). Percentage apoptosis in HCT116 p53+/+ (B) and Jurkat cells (C) are shown (D) HCT116 p53-/- cells were transfected
with plasmids expressing GST, GST-Siva-1, GST-Siva-1∆SAH or GST-Siva-1∆C (residues 130-149) as described earlier.[8] The cell lysates
were used to determine active caspase-9

endogenous Siva-1 in cancer cell apoptosis engendered by
cisplatin-induced terminal DNA damage.
Siva-1 induces Bax oligomerization

In addition to its transcriptional role, p53 can function
directly at the mitochondrial level and activate Bax, via a
specific interaction with Bcl-xL.[15] In order to assess whether
Siva-1 requires cytoplasmic p53 for its apoptotic function,
we expressed Siva-1 in HCT116 p53-/- cells. Cells were
transiently transfected with a GST-tagged Siva-1 or GST alone,
incubated for 24 hours, and treated with cisplatin (100 µM)
for a further 24 hours. Representative lysates were analyzed
4
4

by immunoblotting for caspase-9 processing, a hallmark of
activation of the intrinsic cell death pathway. As shown, a
distinct caspas-9 related p17 cleavage product was visible in
the lysates from Siva-1 expressing cells exposed to cisplatin;
conversely, we were unable to detect this product in the case of
cells expressing GST alone [Figure 2D, upper panel]. Although
the relative expression of Siva-1 was considerably less than that
of GST, it significantly enhanced cisplatin-induced apoptosis
[Figure 2D, middle panel]. As expected, both the mutants
migrated to a similar distance as that of the GST-Siva-1 WT on
a 10% SDS-PAGE, since the difference in molecular weights
was relatively small.We further determined that in contrast to
Journal of Carcinogenesis
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a corresponding control deletion mutant (∆C), a GST-Siva-1
mutant, lacking the SAH region, was deficient in its ability to
promote caspase-9 activation [Figure 2D, upper panel].
The Siva-1 SAH peptide can induce cytochrome c
leakage in isolated mitochondrial fraction

Intrinsic apoptosis mediated by p53-induced apoptotic genes
is characterized by the oligomerization of Bax and Bak whose
function is normally curtailed by anti-apoptotic members
such as Bcl-2 and Bcl-xL. Activated Bax oligomerizes and
inserts into the mitochondrial membrane, thereby forming
channels through which resident pro-apoptotic proteins
such as cytochrome C leak into cytosol.[21] We made use of a
chemical cross-linker (BMH) to observe such potential higher
order Bax structures, as an indicator for intrinsic apoptosis. [22]
MDA-MB-231 cells, known to lack functional p53, were
transfected with either GST or GST-Siva-1 expressing plasmids;
following a 24-hour expression period, cells were treated with
suboptimal doses of cisplatin[13] or DMSO for 24-48 hours.
Harvested lysates were then incubated with BMH, prior to
immunoblotting, to covalently crosslink proteins. Intriguingly,
in GST-Siva-1 expressing cells, Bax appeared to dimerize, even
in the absence cisplatin treatment; following 24 and 48 hours
of drug exposure, oligomeric complexes consistent with Bax
trimers and tetramers, respectively, were observed, suggesting
a clear progression in Bax activation over the experimental time
period [Figure 3, upper right panel]. However, a vast majority
of the Bax protein appeared to remain in a monomeric state
in cells expressing GST, regardless of the duration of cisplatin
treatment [Figure 3, upper left panel]. Expression levels of
GST and GST-Siva-1 were determined and the specificity of
the result upheld [Figure 3, lower panels].
Since proapoptotic BH3-only Bcl-2 family members function
principally at the mitochondrial level, we next investigated
the intracellular localization pattern of Siva-1. HCT116
p53-/- cells were transduced with either Siva-1 or control
IRES-GFP expressing recombinant adenoviruses; following
24 hours of expression, cells were treated with cisplatin and
subjected to hypotonic shock. They were then fractionated
to obtain heavy membrane (mitochondria-enriched) isolates.
Biochemical analysis of cells treated with cisplatin over a 4-8
hour period revealed incremental accumulation of Siva-1 in the
mitochondrial compartment [Figure 4A, upper right panel].
As observed previously, endogenous Siva-1 levels could not be
detected in the p53-/- cell line [Figure 4A, upper left panel].
Whole cell lysate immunoblot analysis confirmed specific and
appropriate viral transduction and Siva-1 expression [Figure
4A, lower panels]. Having verified mitochondrial localization
of Siva-1 in response to genotoxic stress and its independence
of cytoplasmic p53, we further investigated the potential
Journal of Carcinogenesis
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Figure 3: Siva-1 promotes Bax activation in response to cisplatin
treatment. MDA-MB-231 cells transiently expressing GST or
GST-Siva-1 were treated with DMSO or cisplatin (50 µM) for the
indicated time points (upper panels). Cells were iterated with BMH
cross-linker (Pierce) to observe Bax multimers; arrows indicate
monomeric, dimeric, and oligomeric forms (upper panels). In a
parallel experiment, appropriate expression levels and protein
loading were confirmed using GST and and # β; actin antibodies,
respectively (lower panels)

mechanistic consequences of Siva-1 at the mitochondrial level.
We have previously demonstrated that sole expression of the
SAH domain of Siva is sufficient to negate the protective effects
of Bcl-xL and Bcl-2 in response to DNA damage, resulting in
cytochrome C release and consequent caspase-9 activation.[8-9,13]
To investigate the functional relevance of current translocation
data, isolated heavy membrane fractions from MCF-7 cells
stably expressing GFP or a GFP-tagged version of Bcl-xL
were incubated with either 5 [Figure 4B: SAH1, CTL1] or 10
(SAH2, CTL2) µg of synthetic peptides, corresponding to the
SAH region of Siva-1 (amino acid residues 36-55) or a control
downstream region (amino acid residues 130-149). Equivalent
mitochondria (pellet) and corresponding supernatant fractions
were then assessed for cytochrome C by western blot. As
shown, mitochondria from GFP expressing cells exhibited
nearly complete efflux of cytochrome C from pellet fractions,
when treated with either concentration of SAH peptide; this
corresponded with reciprocal accumulation in the supernatant.
Mitochondria treated with either concentration of control
peptide demonstrated comparatively less cytochrome C release
[Figure 4B, left panels]. Interestingly, a similar effect was
observed when mitochondria from cells stably expressing GFPBcl-xL were treated with SAH peptide. Notably, however, higher
peptide concentrations were required for significantly enhanced
cytochrome C efflux. This is likely due to enhanced levels of
expression of Bcl-xL in transfected cells, which necessitated
higher quantities of SAH peptide to overcome the protective
effect of Bcl-xL. Mitochondria treated with control peptide
5
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Figure 5: Siva-1 plays a necessary but partial role in genotoxicinduced apoptosis; p53 is a central player in DNA damage-induced
apoptosis and it triggers transcription of several pro-apoptotic
genes such as Siva-1, Puma, Noxa, Bax etc. Siva-1, though principally
regulated by p53 transcriptional activity, can function independent
of p53 (unlike Puma), whereas Noxa appears to be important for
mediation of ROS-induced cell death. Finally, the apoptosis pathways
are kept in check by cell survival pathways, wherein Siva-1 is known
to inhibit NF-kappa B.[10]

and caspase-9 activation and the twenty amino acid putative
helical region in Siva-1 (SAH) is the principal mediator.

Discussion

Our data demonstrating the dependence of endogenous
Siva-1 expression on induced p53 activity is in accordance
with previous reports published by Pommmier and coworker
(2003) using gene profiling.They showed that the topoisomerase
inhibitor topotecan induces Siva-1 expression (transcripts) in
a p53 dependent manner.[12] A previous study of differential
gene expression analysis using cell cycle and apoptosis DNA
microarray in cisplatin treated Hep3B cells also reveals
significant induction of Siva expression.[11] In addition, our data
is also in agreement with a report previously published by Slack
and coworkers that p53 as well as E2F1 directly activate the
transcription of Siva-1.[4] It is therefore not surprising that p53,
a powerful tumor suppressor, induces apoptosis in susceptible
cells by upregulating transcription of the pro-apoptotic gene
Siva-1. As shown in Figure 2A, Siva-1 knockdown alone appears
to promote cell survival; however, we have observed this only
in HCT116 but not in Jurkat cells and, therefore, disregarded
the observation. The maximum effect of Siva-1, however, was
seen in cells treated with various apoptotic stimuli.[7-10,13]

In this paper, we have shown that Siva-1, a pro-apoptotic protein
that lacks a true BH3 domain, behaves like a small BH3 only
protein and plays a significant and essential but partial role in
genotoxic (p53-induced) apoptosis. Using the colorectal cancer
cell line HCT116, we have clearly shown the dependence of
Siva-1 intracellular expression on functional p53.The expressed
Siva-1 targets mitochondria and induces Bax oligomerization

Although it lacks significant homology to the Bcl-2 family
per se, we have shown here that the ability of Siva-1 to bind
anti-apoptotic proteins like Bcl-xL may consequently result
in direct activation of Bax and cytochrome C release. The
unique putative twenty amino acid SAH region in Siva-1 was
shown by us to be essential for its apoptotic function. Based
on our earlier observation,[10] it appears to behave like the

Figure 4: Siva-1 and cytochrome C release. (A) HCT116 p53-/- cells
were infected with either Siva-1 (Adeno-Siva-1) or GFP (AdenoGFP) and treated as shown. Heavy membrane fraction lysates
were analyzed for Siva-1 and COX IV expression (upper panels);
corresponding whole cell lysate samples were analyzed for Siva-1
and GFP expression levels (lower panel). (B) Heavy membrane
fractions (30 µg) from MCF-7 cells stably expressing either GFP
or GFP-Bcl-xL[8] were incubated with either 5 or 10 µg of SAH or
control peptides. At 30 minutes, the fractions were analyzed for
cytochrome C

elicited little or no effect [Figure 4A, right panels].This suggests
that the SAH region of Siva is both necessary and sufficient to
evoke cytochrome C release from mitochondria, reminiscent
of a BH3 domain-like mechanism, and it supports previous and
current data demonstrating SAH dependent intrinsic apoptotic
initiation via caspase-9 [Figure 2D].

6
6

Journal of Carcinogenesis
A peer reviewed journal in the ﬁeld of Carcinogenesis and Chemoprevention

Journal of Carcinogenesis 2009, 8:2

BH3 only peptide of Bid, in inducing apoptosis.[16] The time
dependent increase in expressed Siva-1 in heavy membrane
fraction, upon cisplatin treatment, is highly likely to be due
its localization to mitochondria, Here we have shown that
treatment of mitochondrial fraction with the above peptide
results in cytochrome C leakage; in our previous studies, we
demonstrated that it can specifically interact with Bcl2 or Bclxl but not Bax.[13] Thus, induction of Siva-1 by p53 (genotoxic
stress) is likely to result in its translocation to mitochondria
and neutralize the pro-survival effects of Bcl2 anti-apoptotic
members.This explains the enhanced Bax oligomerization seen
in cells forced to overexpress Siva-1 [Figure 3].
A large body of work supports the idea that the antiapoptotic
members such as Bcl2 and Bcl-xL counteract the apoptotic
effects of Bax and Bak and thus act as sentinels of cell survival.
Under conditions where the DNA is damaged and irreparable
(genotoxic stress), the relatively small proapoptotic molecules
such as Bid, Bad and Puma interfere with the above interaction,
resulting in the release of Bax and Bak and their oligomerization.
Oligomerization of Bax and Bak, in turn, results in loss in
mitochondrial integrity and leakage of cytochrome c. The
above events are typically induced by small BH3 only apoptotic
molecules that are induced by p53. Siva-1, although induced
by p53, is not a member of the Bcl2 family and yet induces
oligomerization of Bax.
P53 is known to induce intrinsic apoptosis in a transcriptional
independent as well as transcriptional dependent manner.
The most well characterized proapoptotic proteins that are
transcriptionally regulated by p53 are Bax and the BH3 only
protein Puma.[17] In normal cell, the levels of p53 are very
low; however, they are rapidly elevated upon induction of
DNA damage. This results in accumulation of p53 in cytosol.
The apoptotic activity of p53 is neutralized by Bcl2 and Bclxl. Under the above conditions, Puma levels are also known
to increase. It has a high affinity for Bcl2 and Bcl-xL and,
thus, displaces p53 from Bcl2 and Bcl-xl, resulting in intrinsic
apoptosis.[18] There appears to be a strong dependence of Puma
for p53, since it fails to induce significant apoptosis in p53 null
cells.[2,18] In this sense, Siva-1 appears to be different from that of
Puma. Its ability to promote intrinsic cell death does not require
p53, since expression of Siva-1 in p53 null cells also enhances
cisplatin-induced cell death [Figure 2D].[13] Since elimination
of DNA damaged cells to prevent tumorigenesis is a very
important function, it appears to be regulated by redundant
and overlapping pathways. For instance, p53 regulated Noxa
appears to have a definitive role in ROS-induced cell death,
whereas Puma is an essential mediator of DNA damage-induced
cell death.The role of Puma appears to be somewhat limited by
functional p53, although its transcription can also be regulated
Journal of Carcinogenesis
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by E2F1.
Recently, an essential role for Siva-1 was also shown in
campotheticin-induced apoptosis in cerebellar neuronal
granules, that was also p53 dependent. [23] The fact that
expression of Siva-1 can potentiate cisplatin-induced apoptosis
even in the absence of a functional p53 means that Siva-1 is
likely to play a role in genotoxic stress-induced apoptosis, even
if p53 is mutated and non-functional, as is the case with almost
50% of cancers.
Although we have shown that Siva-1 plays an essential and
significant role in cisplatin-induced intrinsic cell death, despite
the knockdown of Siva-1 expression, the cells still undergo
considerable apoptosis.This could be explained by the fact that
p53 induces transcription of several apoptotic genes, other
than Siva-1, and these could be responsible for the residual
cell death.[17]
Conclusions
We have attempted to depict the complex regulation of DNA
damage-induced apoptosis in the model shown in Figure 5.
There is no doubt that p53 is a central player recruited by
the cell, in response to DNA damage, and it decides the fate
of the cell mainly by switching on specific gene transcription
programs. By itself and by positively increasing the transcription
of several apoptotic genes, it triggers intrinsic cell death. Siva-1
is one of the effectors of p53; however, its transcription can
also be triggered by other transcription factors such as E2F1.
Unlike Puma, Siva-1 mediates cell death in a p53 independent
manner. The fact that Siva-1 can also potentially inhibit NFkappa B activation that promotes transcription of several cell
survival molecules[10] also makes Shiva-1 a unique effector of
p53 mediated apoptosis.
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